Revolution Medicines To Advance Lead Cancer Drug With $2 Billion In Funds

benzinga.com/news/health-care/25/06/46081231/revolution-medicines-to-advance-lead-cancer-drug-with-2-billion-in-funds

Revolution Medicines, Inc. (NASDAQ:RVMD) on Tuesday partnered with Royalty Pharma Plc (NASDAQ:RPRX) on $2 billion in flexible funding to support Revolution Medicines’ independent global development and commercialization strategy and operations.
Revolution Medicines retains full strategic…

This story appeared on benzinga.com, 2025-06-24 18:35:32.
The Entire Business World on a Single Page. Free to Use →